Sensitivity of Project: EVO Monitor Cognitive Measurements to Pharmacological Agents
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
This is a study in adults to assess the sensitivity of Project: EVO Monitor cognitive
measurements to two short-acting cognitively active pharmacological agents. The participants
will receive a placebo, and two pharmacological agents in a randomized order for three
in-clinic study days. During each study day in the clinic, the participants will use Project:
EVO Monitor and another cognitive task through the day.